Trade Mark Journal No.2025/025 20 June 2025
UK00004213861 4 June 2025 (5)
EXKALBRI
International priority date claimed: 24 January 2025
(European Union Intellectual Property Office (EUIPO))
(019135271)
- Class 5
- Pharmaceutical preparations and substances for the treatment of cardiovascular, metabolic, and renal diseases and disorders.
AstraZeneca AB
Representative: Dennemeyer & Company Limited